These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5599677)

  • 1. [26th Report on the regular meeting of the Central Expert Committee for the drug trade (ZGA) on March 17, 1966 including the meeting of the governing body on January 27, 1966 as well as the consultation on the health care preparations on February 23, 1966].
    Pharm Prax; 1967; 3():70-2. PubMed ID: 5599677
    [No Abstract]   [Full Text] [Related]  

  • 2. [24th Report on the regular meeting of the Central Expert Committee for the drug trade (ZGA) on September 24, 1965 including the meeting of the Governing Body on June 30 and September 2, 1965].
    Pharm Prax; 1966; 10():235-8. PubMed ID: 6001098
    [No Abstract]   [Full Text] [Related]  

  • 3. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [14. Cooperation between the executive committee C 6 "Dyes in medicine and biology" and dye producers].
    Gerbig KD
    Acta Histochem; 1973; Suppl 13(0):321-6. PubMed ID: 4213583
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug supply report and expert pronouncement].
    Rosén A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469312
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of drug product selection in health care and the role of the pharmacy and therapeutics committee.
    Cohen P
    Manag Care Interface; 2006 Dec; 19(12):15-6. PubMed ID: 17274477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 8. [13. The normalization of dyes--postulates, standards of procedure].
    Toepfer Q
    Acta Histochem; 1973; Suppl 13(0):319-20. PubMed ID: 4213587
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing the P & T committee agenda for new drug requests.
    Standish RC; Evans PJ; Bell JE
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The drug commission of German physicians and phase IV screening].
    Ochsenfahrt H
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498
    [No Abstract]   [Full Text] [Related]  

  • 14. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an effective P&T Committee, Part I.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparatory activities for the International Conference on Population and Development 1994.
    Afr Popul Newsl; 1994; (65):2-6. PubMed ID: 12319340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Organization of the German Pharmaceutical Councils and drug control in the so-called General Gouvernement 1939-1945].
    Jeśman C
    Arch Hist Med (Warsz); 1984; 47(3):403-15. PubMed ID: 6393904
    [No Abstract]   [Full Text] [Related]  

  • 19. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.